📌 Key Takeaways
- Topic: Silica MSDS: How to Read It and What Safety Information to Check
- Keywords: silica gel manufacturer
- Published: 2026-11-20 05:55:59
- Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
What Is Silica? A Simple Explanation of Silica, Its Forms and Uses
- Fumed Silica Price: 2026 Price Ranges, Grade Differences and Cost Drivers
- What Is Synthetic Amorphous Silica (SAS)? Types, Safety and Regulatory Status
- Silica Bulk Density: Typical Values by Type and Why It Matters for Handling
- Silica Supply Chain: Raw Materials, Production Hubs and Risks
Silica Demand in 2026: Key Industries Driving Growth
What is silica (SiO₂)?
cristobalite
What is the difference between fumed silica and precipitated silica?
how is silica made Several recent research works can support the prior finding and show that APIs in MSNs sustain their chemical structure, unaffected by covalent bonding during adsorption, storage, or release. Porras et al. observed consistent FTIR peaks for drug-MSN systems (albendazole loaded into SBA-15), confirming the preservation of functional groups [ 50 ]. Ditzinger et al. attained the stabilization of haloperidol and carbamazepine in their amorphous forms through adsorption into mesoporous silica, sustaining their chemical integrity [ 51 ]. PXRD and DSC analyses confirmed that the drugs remained amorphous post-incorporation without recrystallization for at a minimum three months. Particularly, the absence of new PXRD peaks and DSC melting endotherms during this period signals there is no chemical degradation or alteration of the chemical structure [ 51 ]. Minecka et al. demonstrated that while aripiprazole transforms from crystalline to amorphous form upon adsorption into mesoporous silica, the chemical structure of the API remains unchanged [ 52 ]. To track the molecular state of the drug during and after amorphization, calorimetric, X-ray diffraction, and dielectric methods were carried out by the researchers to provide proof. The findings recommend that the steric hindrance impact averts recrystallization, consequently preserving chemical structures as amorphous APIs revert to the original form [ 52 ]. Knapik-Kowalczuk et al. found that celecoxib in Syloid 244FP exhibits stable FTIR and NMR signals and intact molecular dynamics after amorphization, showing stabilization via physical interactions (steric hindrance and surface interactions without extra bond formation) [ 53 ]. Richter et al. converted itraconazole to an amorphous form in the presence of mesoporous silica, without altering its chemical structure, by the twin-screw extrusion method, as confirmed by consistent thermal and diffraction analyses [ 54 ]. Furthermore, Antonino et al. highlighted the transition of naproxen and ibuprofen from crystalline to amorphous when they were adsorbed into mesoporous silica (Syloid 72FP) [ 55 ]. This change is purely physical, with no chemical alterations to the drug molecules. Approaches such as differential scanning calorimetry (DSC), X-ray diffraction (XRPD), and solid-state NMR verify that the APIs' chemical structure of the APIs remains intact throughout and after amorphization. Drug adsorption onto the silica surface creates a stabilized amorphous state that resists recrystallization without changing the chemical bonds of the APIs. This stabilization stems from physical confinement and interactions such as hydrogen bonding or van der Waals forces with the silica, without any chemical reactions or degradation [ 55 ]. In summary, MSNs accomplish API amorphization and stabilization through steric confinement and non-covalent adsorption, thereby preserving chemical structures, as verified by consistent data obtained by researchers.
What drives silica raw material prices?
silica TDS The carriers can have ordered and disordered pore structures [ 1, 2 ]. The ordered mesopores have a regular, homogeneous pore structure and a tunable internal frame, which permits the optimization of the API formulation, while the disordered ones have a random distribution of pore structure. Pores can be divided into two chief groups according to their geometry. There are open and closed pores, based on whether the pore is accessible to the medium or not. In the case of open pores, further differentiation is also possible. Blind pores are only accessible from one direction, while through pores are accessible from at least two directions [ 3 ]. The arrangement of the pores can also be defined and changed, hence the kinetics and dynamics of the release of the API can be influenced and regulated [ 1 ]. Laminar (tubular), radial, hexagonal, or cubic arrangements can also be created [ 1 ]. It is well known that the pore size significantly affects drug loading and drug release [ 1, 3 ]. Nonetheless, the literature is not crystal clear regarding correlation [ 14 ]. Some studies show proof that larger pores provide faster drug release [ 15, 16, 26 ], and larger pores have demonstrated a faster degradation rate in the lymph nodes [ 15 ], and reports limited release for smaller pores as they limit the diffusion process, which is called the steric hindrance influence [ 16, 26 ]. Nevertheless, in other publications, proof recommends that larger pores facilitate slower drug release, as the drug is loaded and trapped in deeper channels, requiring a longer access time for the release medium [ 14 ]. In general, the adsorption capacity can indeed be increased by increasing the specific surface area of the carrier and by decreasing the pore diameter [ 17 ].
/news/article.htmlDisclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.